Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Escherichia coli-derived recombinant human bone morphogenetic protein-2 combined with bone marrow-derived mesenchymal stromal cells improves bone regeneration in canine segmental ulnar defects

Fig. 2

Radiographs of the postoperative changes. ax Postoperative images taken at 4, 8 and 12 weeks after surgery are shown for all six experimental groups: 560 μg rhBMP-2 with 107 (ad), 105 (eh), and 0 (il) cells, and 140 μg rhBMP-2 with 107 (mp), 105 (qt), and 0 (ux) cells. The groups transplanted with BMSCs form more regenerated bone than the groups without cells at the same dose of rhBMP-2

Back to article page